News - Hikma Pharmaceuticals

Filter

Current filters:

Hikma Pharmaceuticals

Popular Filters

9 to 26 of 26 results

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

19-03-2013

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

Hikma delivers revenue growth of 21% and EPS up 24% for 2012

13-03-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region

22-10-2012

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

Solid first-half 2012 results from Jordan's Hikma

16-08-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) has reported its interim results for…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma may invest $100 million in Ukrainian pharma market

15-05-2012

Hikma Pharmaceuticals (LSE: HIK), Jordan's largest pharmaceutical company which is listed on the London…

EuropeFinancialGenericsHikma Pharmaceuticals

Hikma earnings down despite 25.6% revenue growth

14-03-2012

Fast-growing Jordan headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) delivered what it called…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Hikma enters Moroccan market via $111 million controlling stake in Promopharm

05-10-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Hikma unit to increase focus on contract manufacturing, aimed at alleviating US drug shortages

20-09-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that its US subsidiary, West-Ward, is to focus…

GenericsHikma PharmaceuticalsMarkets & MarketingNorth AmericaWest-Ward

Jordan’s Hikma delivers 10.4% sales growth in first half 2011

25-08-2011

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa

17-08-2011

Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

Hikma takes stake in China’s Hubei Haosun to enhance API sourcing

11-07-2011

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has acquired…

GenericsHikma PharmaceuticalsHubei HaosunMergers & AcquisitionsOncology

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body

29-04-2011

The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Hikma takes stake in Indian pharma company Unimark Remedies

18-04-2011

Jordan-headquartered generic drugmaker Hikma Pharmaceuticals (LSE: HIK) revealed on Friday that it has…

Antibiotics and Infectious diseasesAsia-PacificCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsRespiratory and PulmonaryUnimark Remedies

9 to 26 of 26 results

Back to top